{"database": "openregs", "table": "dockets", "rows": [["FDA-1999-N-0114", "FDA", "Current Good Manufacturing Practice for Blood & Blood Components; Notification of Consignees & Transfusion Recipients Receiving Blood & Blood Components at Increased Risk of Transmitting Hepatitis C Virus Infection (\"Lookback\")", "Nonrulemaking", "2025-03-11T08:42:11Z", "0b000064804ae8cc"]], "columns": ["id", "agency_id", "title", "docket_type", "last_modified", "object_id"], "primary_keys": ["id"], "primary_key_values": ["FDA-1999-N-0114"], "units": {}, "query_ms": 0.6696898490190506, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}